Home >> Content

Dr. Salim Merali

Dr. Salim Merali received his BS, MS, and PhD degrees in Biochemistry from The City University of New York. While completing his doctoral program, Dr. Merali joined New York University (1992-2005) to work on drug development on opportunistic fungal pathogens in AIDS (Pneumocystis). He also developed state of the art technology in Proteomics and Metabolomics. He joined Temple University School of Medicine (2005-2013) as Associate Professor of Biochemistry, The Fels Institute of Cancer Research and Molecular Biology, and Director of the Proteomics Core Facility. Dr. Merali joined The School of Pharmacy in November 2013. He is an expert in the study of Pneumocystis infection and the use of S-adenosylmethionine as a marker for monitoring infection. He has been a key liason for translational medicine research with regards to teaching and supervising infectious disease fellows and surgical residents. He has vast expertise in Proteomics and Metabolomics applied to diagnostic medicine in COPD, cancer, Pneumocystis, and neuroAIDS. He is the principal author of seven patents. He is also the principal author or co-author of over sixty publications, and two  book chapters. He has also been a member of numerous NIH study sessions and has been invited to many lectureships.

Temple University
Moulder Center for Drug Discovery Research

Temple University School of Pharmacy
3307 N Broad Street
Philadelphia, PA 19140